4,624
Views
20
CrossRef citations to date
0
Altmetric
Research Article

α-Hederin inhibits the growth of lung cancer A549 cells in vitro and in vivo by decreasing SIRT6 dependent glycolysis

, , , , , , , & show all
Pages 11-20 | Received 15 Jul 2020, Accepted 05 Dec 2020, Published online: 27 Dec 2020

References

  • Annibaldi A, Widmann C. 2010. Glucose metabolism in cancer cells. Curr Opin Clin Nutr Metab Care. 13:466–470.
  • Budanov AV, Karin M. 2008. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 134:451–460.
  • Cheng L, Zhang M, Zhang P, Song Z, Ma Z, Qu H. 2008. Silver complexation and tandem mass spectrometry for differentiation of triterpenoid saponins from the roots of Pulsatilla chinensis (Bunge) Regel. Rapid Commun Mass Spectrom. 22:3783–3790.
  • Dang CV, Kim JW, Gao P, Yustein J. 2008. The interplay between Myc and HIF in cancer. Nat Rev Cancer. 8:51–56.
  • David CJ, Chen M, Assanah M, Canoll P, Manley JL. 2010. Hnrnp proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 463:364–368.
  • Gan L, Xiu R, Ren P, Yue M, Su H, Guo G, Xiao D, Yu J, Jiang H, Liu H, et al. 2016. Metabolic targeting of oncogene Myc by selective activation of the proton-coupled monocarboxylate family of transporters. Oncogene. 35:3037–3048.
  • Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, Gibson M, Epperly M, Levina V. 2013. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer. 12:94–106.
  • Guan Z, Chen L, Zhou Y, Luo Y, Cui Y, Liu R, Shou B. 2020. The synergistic antitumour effect of multi-components from Pulsatilla chinensis saponins in NCI-H460 lung cancer cell line through induction of apoptosis. Pharm Biol. 58:427–437.
  • He T, Zhang Y, Jiang H, Li X, Zhu H, Zheng K. 2015. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med Oncol. 32:187–194.
  • Kapoor S. 2013. Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies. Int J Colorectal Dis. 28:1317–1318.
  • Koppenol WH, Bounds PL, Dang CV. 2011. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 11:325–337.
  • Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV. 2010. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA. 107:2037–2042.
  • Li D, Hyun J, Jeong C, Kim Y, Lee E. 2003. Antiinflammatory activity of alpha-hederin methyl ester from the alkaline hydrolysate of the butanol fraction of Kalopanax pictus bark extract. Biol Pharm Bull. 26:429–433.
  • Li X, Deng S, Liu M, Jin Y, Zhu S, Deng S, Chen J, He C, Qin Q, Wang C, et al. 2018. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Cell Death Dis. 9:133.
  • Liang Y, Liu J, Feng Z. 2013. The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci. 3:9–18.
  • Liu T, Ye L, Guan X, Liang X, Li C, Sun Q, Liu Y, Chen S, Bang F, Liu B. 2013. Immunopontentiating and antitumor activities of a polysaccharide from Pulsatilla chinensis (Bunge) Regel. Int J Biol Macromol. 54:225–229.
  • Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, Qian J, Li R, Tao T, Wei W, et al. 2015. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop. Oncotarget. 6:13006–13018.
  • Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. 2006. p53 Regulates mitochondrial respiration. Science. 312:1650–1652.
  • Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. 2008. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
  • Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, et al. 2006. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 124:315–329.
  • Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, Dang CV. 2000. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 275:21797–21800.
  • Pérez-Escuredo J, Van Hée VF, Sboarina M, Falces J, Payen VL, Pellerin L, Sonveaux P. 2016. Monocarboxylate transporters in the brain and in cancer. Biochim Biophys Acta. 1863:2481–2497.
  • Polivka J, Janku F. 2014. Molecular targets for cancer therapy in the PI3K/Akt/mTOR pathway. Pharmacol Ther. 142:164–175.
  • Potter M, Newport E, Morten KJ. 2016. The Warburg effect: 80 years on. Biochem Soc Trans. 44:1499–1505.
  • Ridoux O, Giorgio CD, Delmas F, Elias R, Mshvildadze V, Dekanosidze G, Kemertelidze E, Balansard G, Timon P. 2001. In vitro antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A(1), in association with pentamidine and amphotericin B. Phytother Res. 15:298–301.
  • Rooney S, Ryan MF. 2005. Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res. 25:2199–2204.
  • Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. 2004. The tumor suppressor p53 down-regulates glucose transporters glut1 and glut4 gene expression. Cancer Res. 64:2627–2633.
  • Sebastián C, Mostoslavsky R. 2015. The role of mammalian sirtuins in cancer metabolism. Semin Cell Dev Biol. 43:33–42.
  • Sebastián C, Zwaans BMM, Silberman DM, Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber D, et al. 2012. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell. 151:1185–1199.
  • Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 271:32529–32537.
  • Semenza GL, Roth PH, Fang HM, Wang GL. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 269:23757–23763.
  • Shi JZ, Liu GT. 1996. Effect of alpha-hederin and sapindoside b on hepatic microsomal cytochrome p-450 in mice. Zhongguo Yao Li Xue Bao. 17:264–266.
  • Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang AC. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A. 94:6658–6663.
  • Shun CT, Lin SK, Hong CY, Lin CF, Liu CM. 2016. Sirtuin 6 modulates hypoxia-induced autophagy in nasal polyp fibroblasts via inhibition of glycolysis. Am J Rhinol Allergy. 30:179–185.
  • Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, Runkel F, Häberlein H. 2009. Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta 2-adrenergic receptors. Biochemistry. 48:3477–3482.
  • Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA A Cancer J Clin. 70:7–30.
  • Ullah MS, Davies AJ, Halestrap AP. 2006. The plasma membrane lactate transporter mct4, but not mct1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem. 281:9030–9037.
  • Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, Hawkins C, Guha A. 2011. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 208:313–326.
  • Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S, Chen Y, Wu K. 2014. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. J Hematol Oncol. 7:87–96.
  • Zhang Y, Yang JM. 2013. Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention. Cancer Biol Ther. 14:81–89.
  • Zhao W, Chang C, Cui Y, Zhao X, Yang J, Shen L, Zhou J, Hou Z, Zhang Z, Ye C, et al. 2014. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α. J Biol Chem. 289:11219–11229.